|Bid||87.60 x 100|
|Ask||94.90 x 100|
|Day's Range||88.33 - 90.50|
|52 Week Range||78.42 - 102.49|
|PE Ratio (TTM)||-26.40|
|Earnings Date||Aug 2, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||113.67|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to BioMarin Pharmaceutical, Inc. Here are 5 ETFs with the largest exposure to BMRN-US. Comparing the performance and risk of BioMarin Pharmaceutical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
On Thursday, shares of Sarepta Therapeutics (SRPT) are surging, up almost 24% to $42.14 per share in morning trading after the biotech company reported second-quarter revenues that blew past expectations in its earnings report yesterday after the bell.
Sarepta Therapeutics, Inc. (SRPT), and BioMarin Pharmaceutical Inc., have settled their ongoing global patent litigation pertaining to exon skipping technology used in Duchenne muscular dystrophy therapies.